南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

丹皮酚通过调节肠道微生物衍生的溶血磷脂,恢复系统性红斑狼疮患者Th17/Treg细胞平衡

Paeoniflorin Modulates Gut Microbiota–Derived Lysophospholipids to Restore Th17/Treg Homeostasis in Systemic Lupus Erythematosus

Yang Yi, Niu Kevin, Zhong Xiuqin, Shen Lulu, Jiang Shan, Zhang Xuan, Yuan Jiajia, Ou Yanhua, Yang Yunsheng, Duan Xinwang, Duan Yuanyuan

Journal:INFLAMMATION

IF:5.4

DOI:10.1007/s10753-026-02573-9

PMID:

Published:2026-08-20

research field:兽医学反刍动物健康微生物学宏基因组学肠道微生物群

Abstract

Objective Systemic lupus erythematosus (SLE) is characterized by dysregulated immune responses. Paeoniflorin (PF), a highly purified monoterpene glycoside derived from Paeonia lactiflora, exhibits immunomodulatory activity, but its mechanisms in SLE remain unclear. This study investigated whether PF ameliorates SLE by modulating the gut microbiota–lipid metabolite axis and restoring Th17/Treg immune balance. Methods Network pharmacology was applied to predict PF-related targets and pathways in SLE. MRL/lpr mice were treated with PF, and disease severity was assessed by clinical manifestations, autoantibody levels, renal function, and histopathology. Intestinal barrier integrity and motility were evaluated in vivo. Th17 and Treg cell populations in intestinal and peripheral immune tissues were analyzed by flow cytometry. Gut microbiota composition was profiled using 16S rRNA gene sequencing, and untargeted LC–MS/MS–based metabolomics of intestinal contents was performed to identify differential metabolites and enriched metabolic pathways. Results PF treatment significantly alleviated lupus-like manifestations in MRL/lpr mice, including reduced splenomegaly and lymphadenopathy, decreased serum anti-dsDNA, ANA, total IgG, and IL-17 levels, and improved renal function and histopathological injury. PF restored Th17/Treg balance by suppressing IL-17–producing CD4⁺ T cells and promoting Foxp3⁺ Treg cells across intestinal and peripheral immune compartments. PF also improved intestinal barrier integrity and reshaped gut microbial composition by reducing inflammation-associated taxa and enriching beneficial bacteria. Metabolomic analysis demonstrated that PF markedly downregulated glycerophospholipid metabolism, particularly reducing lysophosphatidic acid (LPA) and lysophosphatidylcholine (LPC), which have been reported to promote RORγt activity and Th17 differentiation. Correlation analyses linked microbial alterations with lipid metabolite changes and Th17/Treg-associated

本文使用的Yeasen产品

购物车
客服
转染试用